| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 08/09/2006 | CN1813777A Medicine for treating diabetes retina disease |
| 08/09/2006 | CN1813774A Composition containing ganglioside and trivalent chromium and its use |
| 08/09/2006 | CN1813745A 5-HT 1a receptor subtype agonists |
| 08/09/2006 | CN1813733A Vitamin E nicotinate lipide microsphere injection and its preparing method |
| 08/09/2006 | CN1813716A Use of indole-2,3-dione for preparing medicine for cardio-cerehral vascular disease |
| 08/09/2006 | CN1813712A Method for preparing soybean isoflavone tablet |
| 08/09/2006 | CN1813681A Sodium vitamin C powder for injection and its preparing method |
| 08/09/2006 | CN1813674A Sodium vitamin C formulation for intravenous administration and its preparing method |
| 08/09/2006 | CN1268624C A novel crystalline form of 6-hydroxy-3-(4-[2-(piperidine-1-yl)ethoxy] phenoxy)-2-(4-methoxyphenyl) benzo[b] thiophene hydrochloride |
| 08/09/2006 | CN1268618C 1,5-benzothiazepines compounds and its use as antilipemic agent |
| 08/09/2006 | CN1268394C Binding domain-immunoglobulin fusion proteins |
| 08/09/2006 | CN1268391C Use of GLP-1 analogs and derivatives administered peripherally in regulation of obesity |
| 08/09/2006 | CN1268351C Sugar absorption inhibitors and process for producing the same |
| 08/09/2006 | CN1268350C Medicinal compositions for promoting recovery from stress loading and novel matsutake mushroom strain |
| 08/09/2006 | CN1268347C Metal compounds, mixed or sulphated as phosphate binders |
| 08/09/2006 | CN1268339C Use of rosuvastatin (ZD-4522) in the treatment of heterozygous familial hypercholesterolemia |
| 08/09/2006 | CN1268335C Nucleoside analogs with carboxamidine wodified monocyclic base |
| 08/09/2006 | CN1268333C Indolinone compounds for the treatment of disease |
| 08/09/2006 | CN1268331C Use of inhibitors of renin-angiotensin systemin prevention of cardiovascular events |
| 08/09/2006 | CN1268330C Process for producing medicine grade natural vitamin E raw oil |
| 08/09/2006 | CN1268328C Coenzyme q and eicosapentaenoic acid (EPA) |
| 08/09/2006 | CN1268215C Diet cellulose flour for preventing diabets mellitus and preparing method thereof |
| 08/08/2006 | US7087759 for controlling weight; pyrrolidine or piperidine compounds |
| 08/08/2006 | US7087726 Anti-interferon-α antibodies |
| 08/08/2006 | US7087637 Substituted indoles which are PARP inhibitors |
| 08/08/2006 | US7087636 A 4,7-methano-1,2-benzisothiazol-3-one-1,1-dioxide derivatives, for treating cancer, immune modulation |
| 08/08/2006 | US7087635 3-substituted oxindole β3 agonists |
| 08/08/2006 | US7087632 Inhibition of the interaction of RAGE with its ligands; treatment acute and chronic inflammation, the development of diabetic late complications, Alzheimer's disease, erectile dysfunction, and tumor invasion and metastasis. |
| 08/08/2006 | US7087631 Aryltetrazole compounds, and compositions thereof |
| 08/08/2006 | US7087628 Heteroaryl and heterocyclic nitrogen ring containing hydrazide compounds useful for treating neurodegenerative disorderes |
| 08/08/2006 | US7087627 Synergistic mixture of vasculation damaging agent such as tubulin binding agent and inhibitor of forming of nitric oxide; antitumor agents; anticancer agents |
| 08/08/2006 | US7087626 TGF-beta signal transduction inhibitors |
| 08/08/2006 | US7087619 Method for the treatment of urinary incontinence |
| 08/08/2006 | US7087614 Pyrimidine inhibitors of phosphodiesterase (PDE) 7 |
| 08/08/2006 | US7087607 Salts of bicyclic, N-acylated imidazo-3-amines and imidazo-5-amines |
| 08/08/2006 | US7087603 Pyrazole compounds useful as protein kinase inhibitors |
| 08/08/2006 | US7087599 Estrogen receptor modulators |
| 08/08/2006 | US7087579 Human sodium glucose co-transporter 2 (SGLT2) inhibitors; hypoglycemic agents, antidiabetic agents; obesity; prodrugs |
| 08/08/2006 | US7087432 Fad4, Fad5, Fad5-2 and Fad6, novel fatty acid desaturase family members and uses thereof |
| 08/08/2006 | US7087248 Pharmaceutical component based on human parathyroid hormone and a pharmaceutical composition for intranasal administration comprising the component |
| 08/08/2006 | US7087247 Polyesters, method for producing same, and depot medicaments produced from these polyesters |
| 08/08/2006 | US7087246 Controlled release preparation of insulin contains microparticles obtained by microencapsulation of uniform microcystals of insulin using biodegradable polymeric materials. Since the denaturation of insulin that may occur |
| 08/08/2006 | US7087223 Preventives and/or remedies for hyperphosphatemia |
| 08/08/2006 | CA2356985C 5ht1 antagonists for antidepressant therapy |
| 08/08/2006 | CA2282183C Oxy substituted 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinolines |
| 08/03/2006 | WO2006081431A2 Compounds for treating inflammatory and demyelinating diseases |
| 08/03/2006 | WO2006080582A1 Agent for control of function of antigen-presenting cell |
| 08/03/2006 | WO2006080577A1 Indole derivatives |
| 08/03/2006 | WO2006080533A1 3-amino-1,2,4-triazole derivative |
| 08/03/2006 | WO2006080524A1 Medicinal composition for ameliorating or treating glucose intolerance, borderline diabetes, insulin resistance and hyperinsulinemia containing hypoglycemic agent |
| 08/03/2006 | WO2006080519A1 Diamine derivative |
| 08/03/2006 | WO2006080498A1 Tablets containing ornithine hydrochloride |
| 08/03/2006 | WO2006080439A1 Tricyclic compound |
| 08/03/2006 | WO2006080421A1 Spiroketal derivative and use thereof as diabetic medicine |
| 08/03/2006 | WO2006080407A1 Ppar-activating compound |
| 08/03/2006 | WO2006080406A1 Tricyclic compounds |
| 08/03/2006 | WO2006080262A1 Age-2 aptamer |
| 08/03/2006 | WO2006079720A1 Novel heterocyclic oxime derivatives, method for preparing same and use thereof as hypoglycaemic or hypolipidemic agents |
| 08/03/2006 | WO2006079719A2 Novel heterocyclic oxime derivatives, method for preparing same and pharmaceutical compositions containing same |
| 08/03/2006 | WO2006079637A1 Heterocyclic tetracyclic tetrahydrofuran derivatives as 5ht2 inhibitors in the treatment of cns disorders |
| 08/03/2006 | WO2006079611A1 Crystalline forms of rosuvastatin calcium salt |
| 08/03/2006 | WO2006065600A3 N-biaryl and n-arylheteroaryl piperazine derivatives as modulators of the 5ht2c receptor useful for the treatment of disorders related thereto |
| 08/03/2006 | WO2006035277A3 Novel processes for preparing amorphous rosuvastatin calcium and a novel polymorphic form of rosuvastatin sodium |
| 08/03/2006 | WO2003014318A3 Methods for treating diabetes and other blood sugar disorders |
| 08/03/2006 | US20060173204 New 3-aryl propionic acid derivatives and analogs |
| 08/03/2006 | US20060173075 P-(sulfonyl) aryl and heteroarylamines-as anti-inflammatory agents |
| 08/03/2006 | US20060173069 Therapeutic agent for hyperpotassemia and bone disease |
| 08/03/2006 | US20060173066 Remedy for diabetes |
| 08/03/2006 | US20060173056 Proline derivatives and use thereof as drugs |
| 08/03/2006 | US20060173039 Excellent poly (ADP-ribose) synthetase inhibitors; various ischemic diseases, inflammatory diseases, neurodegenerative diseases, diabetes, septic shock, cephalic injury; 1,2-Dihydro-4-[4-(dimethylaminomethyl)phenyl]-5-hydroxy-1-oxoisoquinoline |
| 08/03/2006 | US20060173036 4-{[3-(3-aminopropyl)-5-(diisobutylamino)-3H-imidazo[4,5-b]pyridin-2-yl]amino}-N-methylbenzamide hydrochloride; melanocortin receptors MC4 modulator; analgesic agent; neuropatic pain; antidepressant, anxiolytic agent; obesity |
| 08/03/2006 | US20060173034 Novel 4-anilinoquinoline-3-carboxamides |
| 08/03/2006 | US20060173014 Useful for the prevention and/or treatment of cognitive disorders; 3-Amino-N-(3-nitrophenyl)-6-[4-(pyrrolidin-1-ylsulfonyl)phenyl]pyrazine-2-carboxamide, for example |
| 08/03/2006 | US20060173012 4-(6-(p-substituted phenyl)-3-pyridazinyl)-1-isopropylpiperazines, e.g., 4-[6-(4-Isopropylpiperazin-1-yl)-pyridazin-3-yl]benzonitrile; treatment of diseases or disorders related to the histamine H3 receptor, e.g., obesity, eating disorders, osteoarthritis, type 2 diabetes, allergic rhinitis, & narcolepsy |
| 08/03/2006 | US20060173010 Modulators of TNF-alpha signaling |
| 08/03/2006 | US20060173003 4-Heteroarylamino-7-H(hetero)aryl-substituted, e.g., [6-(propane-2-sulfonyl)-pyridin-3-yl]-[7-(3-trifluoromethyl-pyridin-2-yl)-quinazolin-4-yl ]-amine hydrochloride; the compounds inhibit binding of vanilloid ligands to capsaicin receptors and are used to treat neuropathic pain |
| 08/03/2006 | US20060172971 e.g. 2-[(2-bromo-4-fluoro-phenyl)-hydrazono]-propionic acid ethyl ester; protein tyrosine kinase inhibitor, but does not inhibit ATP binding to the protein tyrosine kinase; and as anticarcinogenic agent, psoriasis, atherosclerosis, or immune system activity |
| 08/03/2006 | US20060172948 Gamma-carboxyglutamate containing conopeptides |
| 08/03/2006 | US20060172005 Tablet and process for producing the same |
| 08/03/2006 | US20060171916 water insoluble polyallylamine copolymer (hydrochloride) crosslinked with epichlorohydrin crosslinking agent; decreasing serum level of phosphate by binding phosphate in gastrointestinal tract, without increasing absorption of any clinically undesirable material, as calcium or aluminum; hyperphosphatemia |
| 08/03/2006 | US20060171888 Miniaturized device; substrate with reservoirs, openings; barriers layer covering aperture |
| 08/03/2006 | US20060171881 Compounds with high monoamine transporter affinity |
| 08/03/2006 | CA2596237A1 Diamine derivative |
| 08/03/2006 | CA2596235A1 Spiroketal derivatives and use thereof as diabetic medicine |
| 08/03/2006 | CA2596156A1 New derivatives of heterocyclic oximes, their preparation process and the pharmaceutical compositions that they contain |
| 08/03/2006 | CA2596144A1 Compounds for treating inflammatory and demyelinating diseases |
| 08/03/2006 | CA2595975A1 Novel heterocyclic oxime derivatives, method for preparing same and use thereof as hypoglycaemic or hypolipidemic agents |
| 08/03/2006 | CA2595218A1 Indole derivatives having inhibitory activity against sodium-dependent glucose transporter |
| 08/03/2006 | CA2595170A1 Heterocyclic tetracyclic tetrahydrofuran derivatives as 5ht2 inhibitors in the treatment of cns disorders |
| 08/03/2006 | CA2594692A1 Crystalline forms of rosuvastatin calcium salt |
| 08/02/2006 | EP1686175A2 Proteins and nucleic acids encoding same |
| 08/02/2006 | EP1686130A1 Pyrrolo[2,3-d]pyrimidine compounds as immunosuppressive agents |
| 08/02/2006 | EP1686119A1 Pyrimidine-4-one derivatives as ldl-pla2 inhibitors |
| 08/02/2006 | EP1685847A1 Beta-amyloid-analogue-T-cell epitop vaccine |
| 08/02/2006 | EP1685840A2 Use of tetrahydrofolates for modulating the homocysteine level |
| 08/02/2006 | EP1685834A1 Use of pinolenic acid for the treatment of obesity |
| 08/02/2006 | EP1685822A1 Glucose absorption inhibitor and process for producing the same |
| 08/02/2006 | EP1685113A1 Substituted pyrazoles as ppar agonists |
| 08/02/2006 | EP1685110A1 Octahydrophenanthrene hydrazide derivatives useful as glucocorticoid receptor modulators |
| 08/02/2006 | EP1685102A1 Melanocortin receptor agonists |